Prediabetes hypoglycemia drug study pulled before enrolling anyone
NCT ID NCT05174507
First seen Feb 22, 2026 · Last updated May 25, 2026 · Updated 14 times
Summary
This study planned to see if two drugs, empagliflozin and anakinra, could help people with prediabetes who experience low blood sugar after eating. The trial was withdrawn before any participants were enrolled, so no results are available. The goal was to reduce symptoms and improve blood sugar control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPRANDIAL HYPOGLYCEMIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.